Elizabeth M Mahoney

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation
    Elizabeth M Mahoney
    Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 40:737-45. 2002
  2. ncbi Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction
    Elizabeth M Mahoney
    Emory Center for Outcomes Research, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
    JAMA 288:1851-8. 2002
  3. ncbi Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial)
    Zefeng Zhang
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30306, USA
    Am J Cardiol 93:404-9. 2004
  4. ncbi The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial
    Zefeng Zhang
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
    Am Heart J 150:175-81. 2005
  5. ncbi Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) tria
    Sean C Beinart
    Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 46:761-9. 2005
  6. ncbi Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
    William S Weintraub
    Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 45:838-45. 2005
  7. ncbi Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure
    William S Weintraub
    Emory University, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
    Circulation 111:1106-13. 2005
  8. ncbi Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial
    Gerald W Staton
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Emory University School of Medicine, Medical Director, Wesley Woods Long Term Hospital, 1821 Clifton Rd NE, Atlanta, GA 30329, USA
    Chest 127:892-901. 2005
  9. ncbi Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial
    John D Puskas
    Division of Cardiothoracic Surgery, Emory University School of Medicine and Emory Center for Outcomes Research, Atlanta, GA, USA
    JAMA 291:1841-9. 2004
  10. ncbi Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial
    Zefeng Zhang
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
    Circulation 108:1694-700. 2003

Detail Information

Publications14

  1. ncbi Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation
    Elizabeth M Mahoney
    Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 40:737-45. 2002
    ..This study evaluated the cost-effectiveness of administering prophylactic intravenous (IV) amiodarone therapy to patients undergoing cardiac surgery according to their predicted risk of postoperative atrial fibrillation...
  2. ncbi Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction
    Elizabeth M Mahoney
    Emory Center for Outcomes Research, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
    JAMA 288:1851-8. 2002
    ....
  3. ncbi Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial)
    Zefeng Zhang
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30306, USA
    Am J Cardiol 93:404-9. 2004
    ..049 for the interaction among treatment, gender, and follow-up for the quality of life domain). Although CABG may be superior to PCI in men, in women, at 1 year after intervention, both procedures appear equally effective...
  4. ncbi The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial
    Zefeng Zhang
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
    Am Heart J 150:175-81. 2005
    ..Data are limited regarding the impact of acute coronary syndromes (ACSs) on the relative benefits of coronary artery bypass grafting (CABG) versus stent-assisted percutaneous coronary intervention (PCI)...
  5. ncbi Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) tria
    Sean C Beinart
    Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 46:761-9. 2005
    ..CONCLUSIONS: Platelet inhibition with clopidogrel loading before PCI followed by therapy for one year is highly cost effective...
  6. ncbi Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
    William S Weintraub
    Emory University, Atlanta, Georgia, USA
    J Am Coll Cardiol 45:838-45. 2005
    ..We sought to evaluate the long-term cost-effectiveness of clopidogrel for up to one year after an acute coronary syndrome (ACS) without ST-segment elevation...
  7. ncbi Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure
    William S Weintraub
    Emory University, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
    Circulation 111:1106-13. 2005
    ..The present study was performed to evaluate the cost-effectiveness of eplerenone compared with placebo in these patients...
  8. ncbi Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial
    Gerald W Staton
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Emory University School of Medicine, Medical Director, Wesley Woods Long Term Hospital, 1821 Clifton Rd NE, Atlanta, GA 30329, USA
    Chest 127:892-901. 2005
    ....
  9. ncbi Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial
    John D Puskas
    Division of Cardiothoracic Surgery, Emory University School of Medicine and Emory Center for Outcomes Research, Atlanta, GA, USA
    JAMA 291:1841-9. 2004
    ..A preliminary report showed OPCAB achieved improved inhospital outcomes, similar completeness of revascularization, and shorter lengths of stay compared with conventional coronary artery bypass grafting (CABG)...
  10. ncbi Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial
    Zefeng Zhang
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
    Circulation 108:1694-700. 2003
    ..During the first postprocedure year, patients' angina burden and physical limitations were alleviated to a greater extent with CABG...
  11. ncbi The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes
    Richard G Bach
    Cardiovascular Division, Washington University Medical Center, St Louis, Missouri 63110, USA
    Ann Intern Med 141:186-95. 2004
    ..Although increasing age is an important risk factor for adverse outcome among patients with acute coronary syndromes, elderly patients are more often managed conservatively...
  12. ncbi Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation
    Elizabeth M Mahoney
    New England Research Institutes, Watertown, MA 02472, USA
    Am Heart J 151:219-27. 2006
    ..We evaluated the long-term cost-effectiveness of clopidogrel use for up to 1 year using patient-level outcomes and resource use from PCI-CURE, and estimates of life expectancy gains based on external sources...
  13. ncbi The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial
    Zefeng Zhang
    Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE 19713, USA
    Am Heart J 152:1153-60. 2006
    ..Relative outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) may differ between younger and older patients. There are no data comparing the age-related CABG versus PCI outcomes in the stent era...
  14. ncbi Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
    William S Weintraub
    Atlanta VA Medical Center, Decatur, GA, USA
    Am Heart J 151:1180-5. 2006
    ..A multilevel regression model will assess cost-effectiveness from a net benefit perspective. These approaches should provide the most detailed assessment available of the cost-effectiveness of PCI for coronary artery disease...